Treatment2020 Spring Qtr 02/24-05/17-PT27 -- Week
11 Final Exam
Submitted 5/1/20 4:33 AM
Atte 63 out of 75 points
mpt
Score
false
Question 1
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and
aggressive behavior. The PMHNP determines which of the following to be the best treatment
option?
Selected Answer: c.
Citalopram (Celexa) or Escitalopram (Lexapro)
Question 2
0 out of 1 points
All drugs that lead to addiction increase in the ventral striatum, which
is also called the .
Selected Answer: d.
Dopamine / substantia nigra
Question 3
1 out of 1 points
The PMHNP is attempting to treat a patient’s chronic pain by having the agent bind the open
1
,channel conformation of VSCCs to block those channels with a “use-dependent” form of
inhibition. Which agent will the PMHNP most likely select?
Selected Answer: b.
2
, Pregabalin (Lyrica)
Question 4
1 out of 1 points
A patient addicted to heroin is receiving treatment for detoxification. He begins to experience
autonomic hyperactivity during the drug withdrawal period. What medication will the
PMHNP prescribe for this patient?
Selected Answer: c.
Clonidine (CATAPRES)
Question 5
1 out of 1 points
A patient with chronic insomnia asks the PMHNP if they can first try an over-the-counter
(OTC) medication before one that needs to be prescribed to help the patient sleep. Which is
the best response by the PMHNP?
Selected c.
Answer:
“You can get melatonin over the counter, which will help with sleep
onset.”
Question 6
0 out of 1 points
Antipsychotics are doses at a level that blocks % of D2 receptors.
Selected Answer: c.
20-40
Question 7
1 out of 1 points
3